A

Ainos
D

AIMD

0.52060
USD
0.02
(4.12%)
مغلق
حجم التداول
2,902
الربح لكل سهم
0
العائد الربحي
-
P/E
-0
حجم السوق
10,911,883
أصول ذات صلة
ABT
ABT
-1.740
(-1.30%)
132.260 USD
BDX
BDX
-2.180
(-1.27%)
169.970 USD
BSX
BSX
0.210
(0.21%)
101.710 USD
EW
EW
-1.530
(-2.05%)
73.280 USD
I
ICUI
-3.430
(-2.57%)
129.840 USD
ISRG
ISRG
-7.05
(-1.36%)
511.91 USD
MDT
MDT
-1.740
(-1.98%)
86.210 USD
PODD
PODD
-2.24
(-0.73%)
304.32 USD
SYK
SYK
-3.85
(-1.02%)
373.31 USD
TMO
TMO
-14.95
(-3.69%)
390.27 USD
المزيد
الأخبار المقالات

العنوان: Ainos

القطاع: Healthcare
الصناعة: Medical Devices
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, andtelehealth-friendly POCTs powered by the AI Nose technology platform.